Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. - Moldovan, D.; Reshef, A.; Fabiani, J.; Kivity, S.; Toubi, E.; Shlesinger, M.; Triggiani, M.; Montinaro, V.; Cillari, E.; Realdi, G.; Cancian, M.; Visscher, S.; et al. (Clinical & Experimental Allergy, 2012)